New Key Statistics Module, Z-Score and F-Score
DHA:SQURPHARMA Key Ratios
Market Cap BDT M | 188,282.20 |
Enterprise Value BDT M | 138,415.00 |
P/E(ttm) | 9.06 |
PE Ratio without NRI | 9.02 |
Forward PE Ratio | 7.84 |
Price/Book | 1.43 |
Price/Sales | 2.74 |
Price/Free Cash Flow | 23.48 |
Price/Owner Earnings | 10.35 |
Payout Ratio % | 0.44 |
Revenue (TTM) BDT M | 69,388.00 |
EPS (TTM) BDT | 23.71 |
Beneish M-Score | -2.13 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | 7.50 |
y-y EBITDA Growth Rate % | 2.10 |
EV-to-EBIT | 6.13 |
EV-to-EBITDA | 5.57 |
PEG | 1.20 |
Shares Outstanding M | 886.45 |
Net Margin (%) | 30.29 |
Operating Margin % | 25.00 |
Pre-tax Margin (%) | 32.16 |
Quick Ratio | 9.34 |
Current Ratio | 11.41 |
ROA % (ttm) | 15.78 |
ROE % (ttm) | 16.98 |
ROIC % (ttm) | 19.06 |
Dividend Yield % | 5.18 |
Altman Z-Score | 16.86 |
DHA:SQURPHARMA Number of Guru Trades
DHA:SQURPHARMA Volume of Guru Trades
Gurus Latest Trades with DHA:SQURPHARMA
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
DHA:SQURPHARMA is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data